Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WWZAS
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
SYS6010
|
|||||
| Synonyms |
SYS 6010; SYS-6010; SYS6010; CPO 301; CPO-301; CPO301
Click to Show/Hide
|
|||||
| Organization |
CSPC Pharmaceutical Group Ltd.
|
|||||
| Drug Status |
Phase 3
|
|||||
| Indication |
In total 3 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
JS-1
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
